Close
  • Home

CAR-T Digest - August 2020

CAR-T Digest - August 2020

CAR-T Digest - August 2020

CAR-T Digest - August 2020

Funding

Regulatory  ·  Weekly Digest - 15 August to 21 August 2026
CStone Pharmaceuticals receives NMPA IND approval for CS5007

Weekly Digest – August 2026 Weekly Digest – August 2026 21 August 2026: CStone Pharmaceuticals receives NMPA IND approval for CS5007 CStone Pharmaceuticals announced that China’s NMPA has approved the IND application for CS5007, an EGFR/HER3 bispecific ADC, through the […]

by Sandhya Ramalingam

Continue Reading
Clinical  ·  Weekly Digest - 15 August to 21 August 2026
Enhertu significantly improved PFS as 1L treatment in HER2-mutant advanced NSCLC in the phase 3 DESTINY-Lung04 trial

Weekly Digest – August 2026 Weekly Digest – August 2026 17 August 2026: Enhertu significantly improved PFS as 1L treatment in HER2-mutant advanced NSCLC in the phase 3 DESTINY-Lung04 trial AstraZeneca and Daiichi Sankyo announced that Enhertu demonstrated a statistically […]

by Sandhya Ramalingam

Continue Reading
Clinical  ·  Weekly Digest - 15 August to 21 August 2026
Iza-bren phase 3 trial met its primary endpoint in locally advanced/metastatic NSCLC

Weekly Digest – August 2026 Weekly Digest – August 2026 18 August 2026: Iza-bren phase 3 trial met its primary endpoint in locally advanced/metastatic NSCLC Biokin announced that the phase 3 BL-B01D1-301 trial of Iza-bren met its pre-specified primary endpoint of […]

by Sandhya Ramalingam

Continue Reading
Deals  ·  Weekly Digest - 15 August to 21 August 2026
Akiram Therapeutics and ITM signed a Lu-177 supply agreement to support AKIR001 development in Solid tumors

Weekly Digest – August 2026 Weekly Digest – August 2026 20 August 2026: Akiram Therapeutics and ITM signed a Lu-177 supply agreement to support AKIR001 development in Solid tumors Akiram Therapeutics and ITM Isotope Technologies Munich have signed an agreement […]

by Sandhya Ramalingam

Continue Reading
Approval  ·  Weekly Digest - 08 August to 14 August 2026
Enhertu with Pertuzumab approved in China for 1L HER2-positive metastatic Breast cancer

Weekly Digest – August 2026 Weekly Digest – August 2026 12 August 2026: Enhertu with Pertuzumab approved in China for 1L HER2-positive metastatic Breast cancer Daiichi Sankyo and AstraZeneca’s Enhertu plus pertuzumab has been approved by China’s NMPA for the […]

by Sandhya Ramalingam

Continue Reading
Approval  ·  Weekly Digest - 08 August to 14 August 2026
Hengrui’s Aiweida receives NMPA approval for HER2-positive Colorectal cancer

Weekly Digest – August 2026 Weekly Digest – August 2026 07 August 2026: Hengrui’s Aiweida receives NMPA approval for HER2-positive Colorectal cancer Hengrui Pharma’s HER2-targeted ADC Aiweida has been approved in China for the treatment of adults with HER2-positive colorectal […]

by Sandhya Ramalingam

Continue Reading
Approval  ·  Weekly Digest - 08 August to 14 August 2026
AbbVie’s Elahere receives Minzdrav approval in Russia for Ovarian, Fallopian tube and Peritoneal cancer

Weekly Digest – August 2026 Weekly Digest – August 2026 07 August 2026: AbbVie’s Elahere receives Minzdrav approval in Russia for Ovarian, Fallopian tube and Peritoneal cancer AbbVie’s ELAHERE has been approved in Russia for the treatment of epithelial ovarian, […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly Digest - 08 August to 14 August 2026
Celltrion’s CT-P73 receives US FDA FTD for recurrent/metastatic Cervical cancer

Weekly Digest – August 2026 Weekly Digest – August 2026 13 August 2026: Celltrion’s CT-P73 receives US FDA FTD for recurrent/metastatic Cervical cancer Celltrion announced that the U.S. FDA has granted Fast Track designation to CT-P73, a Tissue Factor-targeted ADC, […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly Digest - 08 August to 14 August 2026
ITM receives Complete Response Letter for ITM-11

Weekly Digest – August 2026 Weekly Digest – August 2026 10 August 2026: ITM receives Complete Response Letter for ITM-11 ITM announced that the U.S. FDA issued a Complete Response Letter for the NDA of 177Lu-edotreotide, an investigational targeted radiotherapeutic […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly Digest - 08 August to 14 August 2026
Asieris received FDA IND approval for APL 2501 for the treatment of advanced Solid tumors

Weekly Digest – August 2026 Weekly Digest – August 2026 13 August 2026: Asieris received FDA IND approval for APL‑2501 for the treatment of advanced Solid tumors Asieris Pharmaceuticals announced that the U.S. FDA has cleared the IND application for […]

by Sandhya Ramalingam

Continue Reading
« First‹ Previous5678910111213Next ›Last »
Page 9 of 63


Contact:

  info@ciscientists.com

 +1-908-212-7484

Optimal Dose

For a subscription, please provide your email id